ORMP
Oramed Pharmaceuticals Inc
NASDAQ: ORMP · HEALTHCARE · BIOTECHNOLOGY
$3.88
+1.04% today
Updated 2026-04-30
Market cap
$163.00M
P/E ratio
2.69
P/S ratio
81.50x
EPS (TTM)
$1.50
Dividend yield
—
52W range
$2 – $4
Volume
0.1M
Oramed Pharmaceuticals Inc (ORMP) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-361613.00 | $-611000.00 | $-1.84M | $-2.25M | $-1.42M | $-1.67M | $-2.30M | $-3.40M | $-4.07M | $-4.95M | $4.66M | $-5.83M | $-14.66M | $-12.94M | $-12.44M | $-21.18M | $-28.70M | $-10.29M | $-8.41M | $-9.14M |
| Capital expenditures | $3.00 | $1999.00 | $112012.00 | $7557.00 | $1.42M | $2175.00 | $2132.00 | $6378.00 | $14000.00 | $1000.00 | $9000.00 | $6999.00 | $4999.00 | $14999.00 | $81999.00 | $374999.00 | $495999.00 | $253999.00 | $17999.00 | $9000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | $553199.00 | $807826.00 | $529326.00 | $271158.00 | $719219.00 | $1.47M | $1.35M | $634000.00 | $1.57M | $1.55M | $808000.00 | $465000.00 | $2.69M | $11.51M | $4.21M | $4.05M | $5.99M |
| Free cash flow | $-361616.00 | $-612999.00 | $-1.95M | $-2.26M | $-2.84M | $-1.67M | $-2.30M | $-3.40M | $-4.08M | $-4.95M | $4.65M | $-5.84M | $-14.66M | $-12.95M | $-12.52M | $-21.56M | $-29.20M | $-10.55M | $-8.43M | $-9.15M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $10.87M |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |